In this video, Kai Rejeski, MD, Memorial Sloan Kettering Cancer Center, New York, NY, briefly outlines the different neutrophil recovery phenotypes observed in patients following CD19 CAR T-cell therapy. This interview took place at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.